Brookwood Investment Group »

Ascendis Pharma AS shares owned by Brookwood Investment Group

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by Brookwood Investment Group from 13F filings

Historical chart of Brookwood Investment Group investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by Brookwood Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by Brookwood Investment Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $852k 3.2k 266.72

More positions owned by Brookwood Investment Group

Vanguard Index Fds Total Stk Mkt Put Option (VTI)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Growth Etf (VUG)
Apple Put Option (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Ishares Gold Tr Ishares New Call Option (IAU)
Micron Technology (MU)
Meta Platforms Cl A (META)
Simplify Exchange Traded Fun Aggregate Bd Etf (AGGH)
Ishares U S Etf Tr Shor Dura Bd Etf (NEAR)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Listed Fds Tr Shares Core Bd (OVB)

View all positions for Brookwood Investment Group

Top funds holding Ascendis Pharma AS

RA Capital Management
venBio Select Advisor
Westfield Capital Management Company
Jupiter Topco
FMR
Artisan Partners Limited Partnership
BlackRock
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Franklin Resources
Wellington Management Company
T. Rowe Price Associates
American Century Companies
Perceptive Advisors
Principal Financial Group

View all funds holding Ascendis Pharma AS